Video Experimental Relacionado
Updated: Jul 18, 2026
12:57
Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Neurotoxicidad y neurodegeneración cuando el PrP se acumula en el citosol
Jiyan Ma1, Robert Wollmann, Susan Lindquist
1Howard Hughes Medical Institute, Department of Pathology, University of Chicago, 5841 South Maryland Avenue, Chicago, IL 60637, USA.
Science (New York, N.Y.)
|October 19, 2002
Resumen
La proteína priónica mal plegada (PrP) que se acumula en el citosol es altamente neurotóxica, causando ataxia y degeneración cerebelosa en ratones. Esta especie de PrP citosólico es distinta de la isoforma PrP (Sc) que se propaga por sí misma.
Área de la Ciencia:
- La neurociencia es la neurociencia.
- Biología Molecular Biología Molecular
- Enfermedades por mal plegamiento de las proteínas Enfermedades por mal plegamiento de las proteínas.
Sus antecedentes:
- El mal plegamiento de la proteína priónica (PrP) está relacionado con trastornos neurodegenerativos fatales.
- Las especies específicas de PrP neurotóxicas permanecen sin identificar.
- Las proteínas mal plegadas que son traficadas a través del retículo endoplasmático a menudo son degradadas por los proteasomas citosólicos.
Objetivo del estudio:
- Para investigar la neurotoxicidad de la proteína priónica citosólica (PrP).
- Para determinar si la acumulación de PrP citosólico causa neurodegeneración.
- Para dilucidar un mecanismo potencial para la neurotoxicidad inducida por la proteína priónica.
Principales métodos:
- Utilizó células cultivadas y modelos de ratones transgénicos.
- Estudió los efectos del transporte retrógrado de la proteína priónica mal plegada (PrP) al citosol.
- Se observaron las consecuencias de la acumulación de PrP citosólico en la salud y el comportamiento neuronales.
Principales resultados:
- Incluso pequeñas cantidades de proteína priónica citosólica (PrP) fueron altamente neurotóxicas in vitro e in vivo.
- Los ratones transgénicos que acumulaban PrP citosólico se desarrollaron normalmente, pero más tarde exhibieron ataxia severa, degeneración cerebelosa y gliosis.
- Se identificó una especie de PrP neurotóxica distinta de la isoforma PrP (Sc).
Conclusiones:
- La acumulación citosólica de la proteína priónica mal plegada (PrP) es un potente mecanismo neurotóxico.
- Esta vía establece una nueva ruta para la neurodegeneración de la proteína priónica.
- Sugiere un marco patogénico común para varios trastornos de la proteína priónica.
Videos de Conceptos Relacionados
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:29Excitatory and Inhibitory Effects of Neurotransmitters
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...